299 related articles for article (PubMed ID: 15337704)
41. Statins for aortic stenosis.
Rosenhek R
N Engl J Med; 2005 Jun; 352(23):2441-3. PubMed ID: 15944429
[No Abstract] [Full Text] [Related]
42. Statins for progression of aortic valve stenosis and the best evidence for making decisions in health care.
Thiago L; Tsuj SR; Atallah AN; Puga ME; de Góis AF
Sao Paulo Med J; 2011 Jan; 129(1):41-5. PubMed ID: 21437508
[TBL] [Abstract][Full Text] [Related]
43. [The role of statins in vascular and valvular calcification].
Kozaki K
Clin Calcium; 2006 Jan; 16(1):31-6. PubMed ID: 16397348
[TBL] [Abstract][Full Text] [Related]
44. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement.
Pai RG; Kapoor N; Bansal RC; Varadarajan P
Ann Thorac Surg; 2006 Dec; 82(6):2116-22. PubMed ID: 17126122
[TBL] [Abstract][Full Text] [Related]
45. eComment: Statins decelerate the sclerosis progression of senile aortic valves in only selected cases.
Apostolakis E; Koniari I
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):689. PubMed ID: 18664673
[No Abstract] [Full Text] [Related]
46. SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory.
Rajamannan NM; Greve AM; Moura LM; Best P; Wachtell K
Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):355-67. PubMed ID: 25797901
[TBL] [Abstract][Full Text] [Related]
47. Statin therapy of calcific aortic stenosis: hype or hope?
Liebe V; Brueckmann M; Borggrefe M; Kaden JJ
Eur Heart J; 2006 Apr; 27(7):773-8. PubMed ID: 16399777
[TBL] [Abstract][Full Text] [Related]
48. The role of statins in aortic stenosis. Myth or reality?
Moura LM; Zamorano J; Peréz-Oteyza C; Rocha-Gonçlves F; Rajamannan NM
Rev Port Cardiol; 2007 Jan; 26(1):51-62. PubMed ID: 17427836
[TBL] [Abstract][Full Text] [Related]
49. Calcific aortic stenosis and statin therapy: a new insight.
Roncalli J; Carrié D; Galinier M
Int J Cardiol; 2009 Jan; 131(2):275-6; author reply 276-7. PubMed ID: 17825931
[TBL] [Abstract][Full Text] [Related]
50. Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve.
Kutryb-Zajac B; Jablonska P; Hebanowska A; Lango R; Rogowski J; Slominska EM; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1389-1399. PubMed ID: 32126886
[TBL] [Abstract][Full Text] [Related]
51. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Clin Neuropharmacol; 2011; 34(6):234-40. PubMed ID: 21996648
[TBL] [Abstract][Full Text] [Related]
52. Calcific aortic valve disease should not be considered as a degenerative disease anymore.
Li YB; Hu CL; Liu J; Tang QZ; Huang CX
Med Hypotheses; 2007; 68(6):1233-5. PubMed ID: 17011715
[TBL] [Abstract][Full Text] [Related]
53. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
54. Effect of statin treatment on aortic valve and coronary artery calcification.
Mohler ER; Wang H; Medenilla E; Scott C
J Heart Valve Dis; 2007 Jul; 16(4):378-86. PubMed ID: 17702362
[TBL] [Abstract][Full Text] [Related]
55. Do statins slow the process of calcification of aortic tissue valves?
Gilmanov D; Bevilacqua S; Mazzone A; Glauber M
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):297-301. PubMed ID: 20570976
[TBL] [Abstract][Full Text] [Related]
56. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory effects of statins in patients with aortic stenosis.
Pate GE; Tahir MN; Murphy RT; Foley JB
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):201-6. PubMed ID: 14506545
[TBL] [Abstract][Full Text] [Related]
58. Aortic stenosis and lipids: does intervention work?
Wierzbicki AS; Viljoen A; Chambers JB
Curr Opin Cardiol; 2010 Jul; 25(4):379-84. PubMed ID: 20414108
[TBL] [Abstract][Full Text] [Related]
59. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis.
Nadrous HF; Ryu JH; Douglas WW; Decker PA; Olson EJ
Chest; 2004 Aug; 126(2):438-46. PubMed ID: 15302729
[TBL] [Abstract][Full Text] [Related]
60. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
Bianchi S; Bigazzi R; Campese VM
Am J Kidney Dis; 2010 Apr; 55(4):671-81. PubMed ID: 20097461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
